` 301293 (Sanbo Hospital Management Group Ltd) vs Shanghai Composite Comparison - Alpha Spread

S
301293
vs
S
Shanghai Composite

Over the past 12 months, Sanbo Hospital Management Group Ltd has significantly outperformed Shanghai Composite, delivering a return of +52% compared to the Shanghai Composite's +24% growth.

Stocks Performance
301293 vs Shanghai Composite

Loading
301293
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301293 vs Shanghai Composite

Loading
301293
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
301293 vs Shanghai Composite

Loading
301293
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sanbo Hospital Management Group Ltd vs Peers

Shanghai Composite
301293
JXN
TNL
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sanbo Hospital Management Group Ltd
Glance View

Market Cap
16.4B CNY
Industry
Health Care

Sanbo Hospital Management Group Ltd., rooted in the bustling heart of China's healthcare sector, stands as a beacon of modern medical management and innovation. Founded with the mission to address the ever-growing healthcare demands of an expanding urban population, Sanbo has adeptly navigated the complexities of the industry through its impressive network of specialized hospitals and clinics. This enterprise thrives by streamlining hospital operations and fostering an environment where cutting-edge technologies meet compassionate care. By focusing primarily on neurology, a field with increasing incidence and demand globally, Sanbo captures a niche market. Its approach showcases a blend of expertise, employing skilled medical professionals coupled with state-of-the-art medical facilities, thereby enhancing the quality of patient outcomes and drawing a steady stream of clientele. The company's revenue engine hums efficiently by scaling its specialized services and implementing a multi-layered service model. Sanbo generates income through various channels, including direct patient care, diagnostic services, surgical treatments, and long-term patient management programs. Additionally, the firm harnesses strategic partnerships and collaborations with both public and private sectors to expand its reach and improve healthcare accessibility. A notable portion of its revenue also emanates from offering consultancy services to lesser-equipped hospitals looking to optimize their operations. By spearheading initiatives in research and development, Sanbo not only broadens its expertise but also attracts intellectual capital and investments. Each layer of its operations synergistically works to strengthen its foothold in the healthcare market, creating a sustainable model that continues to thrive amidst the evolving medical landscape.

Intrinsic Value
26.09 CNY
Overvaluation 67%
Intrinsic Value
Price
S
Back to Top